Onconova Therapeutics (NASDAQ: ONTX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Onconova Therapeutics (NASDAQ: ONTX) through any online brokerage.
The latest price target for Onconova Therapeutics (NASDAQ: ONTX) was reported by Ladenburg Thalmann on Tuesday, March 1, 2022. The analyst firm set a price target for 7.00 expecting ONTX to rise to within 12 months (a possible 440.54% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Onconova Therapeutics (NASDAQ: ONTX) is $1.295 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Onconova Therapeutics.
Onconova Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Onconova Therapeutics.
Onconova Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.